Group 1 - The core viewpoint of the article highlights the strategic partnership between Suzhou Yusen Pharmaceutical Co., Ltd. and Sichuan Modern Traditional Chinese Medicine Innovation Technology Co., Ltd. to develop innovative traditional Chinese medicine products [1] - The collaboration focuses on two innovative TCM products, "Xiaoxian Zhihuan Oral Liquid" and "Tiandan Dingxuan Granules," aiming to enhance the research and industrialization of TCM [1] - The partnership aims to integrate technology, clinical, and industrial resources to cover the entire chain of preclinical research, clinical research, registration, and post-market promotion [1] Group 2 - Yusen Pharmaceutical emphasizes the combination of technology and industry, creating a complete innovation loop from laboratory research to clinical application [2] - Sichuan Modern Traditional Chinese Medicine Innovation Technology Co., Ltd. plans to deepen exploration in areas such as international registration of TCM and the development of health products [2] - The collaboration is expected to contribute to the construction of a Sino-Sichuan TCM innovation corridor, facilitating the global market entry of Chinese TCM new drugs [2]
苏州玉森新药开发有限公司与四川省现代中药创新技术有限公司签署产品合作协议
Zhong Zheng Wang·2025-08-23 08:53